Plants Med Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 23-10-2024
- Paid Up Capital ₹ 0.96 M
as on 23-10-2024
- Company Age 29 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.18 Cr
as on 23-10-2024
- Satisfied Charges ₹ 2.19 M
as on 23-10-2024
- Revenue -45.14%
(FY 2023)
- Profit 1.68%
(FY 2023)
- Ebitda 94.94%
(FY 2023)
- Net Worth -40.38%
(FY 2023)
- Total Assets 46.34%
(FY 2023)
About Plants Med Laboratories
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.96 M.
The company currently has active open charges totaling ₹2.18 Cr. The company has closed loans amounting to ₹2.19 M, as per Ministry of Corporate Affairs (MCA) records.
Rakesh Gautam, Kalpana Sharma, and Mahesh Sharma serve as directors at the Company.
- CIN/LLPIN
U85195RJ1995PTC010454
- Company No.
010454
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Jul 1995
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Plants Med Laboratories Private Limited offer?
Plants Med Laboratories Private Limited offers a wide range of products and services, including Black Tea, Tea Sticks, Ayurvedic Medicine, Herbal Products, Ayurvedic Skincare Capsules & Tablets, Diabetic Herbal Medicine, Diabetic Herbal Tablets & Capsules, Common Disease Medicines, Pharmaceutical Tablets, Pharmaceutical Capsules.
Who are the key members and board of directors at Plants Med Laboratories?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kalpana Sharma  | Director | 25-Jul-1995 | Current |
| Rakesh Gautam | Director | 25-Jul-1995 | Current |
| Mahesh Sharma | Additional Director | 07-Oct-2020 | Current |
Financial Performance of Plants Med Laboratories.
Plants Med Laboratories Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 45.14% decrease. The company also saw a slight improvement in profitability, with a 1.68% increase in profit. The company's net worth observed a substantial decline by a decrease of 40.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Plants Med Laboratories?
In 2022, Plants Med Laboratories had a promoter holding of 99.47% and a public holding of 0.53%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 31 Dec 2023 | ₹4.80 M | Open |
Others Creation Date: 23 Nov 2022 | ₹1.20 Cr | Open |
Others Creation Date: 24 Mar 2017 | ₹5.00 M | Open |
How Many Employees Work at Plants Med Laboratories?
Unlock and access historical data on people associated with Plants Med Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Plants Med Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Plants Med Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
